Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Sophia Claire 2025 Jul 14, 13:20

Trump Admin Leverages Fed Renovation for Powell Ouster Amid Rate Dispute

Emma Rose 2025 Jul 14, 13:20

Pound Sterling Outlook: Interest Rates and Economic Indicators in Focus

Sophia Claire 2025 Jul 14, 09:20

Trump's Tariff Threat Looms: Will It Trigger EU Recession and Force ECB Rate Cuts?

Noah Lee 2025 Jul 14, 08:23

Federal Reserve Renovation Project: Defending Costs and Features

Emma Rose 2025 Jul 14, 08:23

Musk Joins Calls for 'Epstein List' Release as Trump Urges MAGA Unity

Frances Wang 2025 Jul 13, 16:00

Crypto News Today: Bitcoin Price (BTC-USD) Is over $119K

Cryptocurrencies
Tommy Yap 2025 Jul 13, 16:00

Morning Note: Gold Gains on Tariffs; Trump Targets EU/Mex; Japan Poll

Morning Note Central Banks Forex
Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices

Info

Spread

0.05

Spread (%)

0.7236 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1107874816

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot